Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务:
资源简介:
This phase III study will compare two combinations of irinotecan, Folfiri versus Xeliri, with the addition of Avastin as 1st line treatment of colorectal cancer.
创建时间:
2006-12-15



